Trials / Completed
CompletedNCT03868254
Chart Review of XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)
XEN 45 Gel Stent: Long Term Performance and Safety Assessment (XEN LT)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 174 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A retrospective, non-interventional, observational, multi-center, chart review study to be conducted in participants who underwent placement of the XEN 45 Gel Stent as a standalone procedure or in combination with phacoemulsification from 1 January 2014 to 1 October 2015.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | XEN Group | Chart review was conducted in participants with open angle glaucoma who underwent placement of the implant XEN 45 Gel Stent as a standalone procedure from 1 January 2014 to 1 October 2015. |
| PROCEDURE | Phacoemulsification | Chart review was conducted in participants with open angle glaucoma who underwent placement of the implant XEN 45 Gel Stent in combination with phacoemulsification (Phaco) from 1 January 2014 to 1 October 2015. |
Timeline
- Start date
- 2019-04-05
- Primary completion
- 2019-10-25
- Completion
- 2019-10-25
- First posted
- 2019-03-11
- Last updated
- 2020-11-17
- Results posted
- 2020-11-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03868254. Inclusion in this directory is not an endorsement.